Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Fuji
McKinsey
Citi
Boehringer Ingelheim
US Department of Justice
Deloitte
QuintilesIMS
Julphar

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,952,340

« Back to Dashboard

Summary for Patent: 5,952,340
Title: Use of granisetron for the treatment of postoperative nausea and vomiting
Abstract:The present invention is directed to a method for the treatment of post-operative nausea and vomiting wherein granisetron is administered to a patient in need thereof.
Inventor(s): Sanger; Gareth John (Sawbridgeworth, GB), Davey; Philip Timothy (Bishop's Stortford, GB), Dott; Christopher Stuart (Reigate, GB)
Assignee: SmithKLine Beecham p.l.c. (Brentford, GB)
Application Number:08/525,521
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,952,340

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,952,340

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9305593Mar 18, 1993
PCT Information
PCT FiledMarch 15, 1994PCT Application Number:PCT/EP94/00820
PCT Publication Date:September 29, 1994PCT Publication Number: WO94/21257

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Dow
Cantor Fitzgerald
Fish and Richardson
Queensland Health
Teva
Boehringer Ingelheim
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.